Papua New Guinea

Last Updated 20 October 2021.

3 Vaccines Approved for Use in Papua New Guinea

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 75 countries

  13 trials in 16 countries

  Approval Source: postcourier.com.pg

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 124 countries

  45 trials in 23 countries

  Approval Source: unicef.org

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  BBIBP-CorV (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 67 countries

  14 trials in 2 countries

  Approval Source: xinhuanet.com

  Inactivated

0 Vaccines in Clinical Trials in Papua New Guinea